Skip to main content
. 2021 Nov 18;12:711906. doi: 10.3389/fendo.2021.711906

Figure 6.

Figure 6

MD-refined allosteric binding modes of ticagrelor to VPAC1/VPAC2/PAC1. MD simulations of VPAC1/VPAC2/PAC1 complexes demonstrated the impact of the R6.40/K6.40 mutation in the NAM-binding region on receptor interactions with ticagrelor (green). The VPAC2-ticagrelor complex was shown in grey, VPAC1-ticagrelor – in orange, and PAC1-ticagrelor – in yellow. Hydrogen bonds in the VPAC2-ticagrelor complex were marked in red and ticagrelor was depicted with sticks. Here, only R6.40/K6.40 were shown in detail in all three receptors because other binding site residues were the same.